Prevalence, Risk Factors, and Sequelae of Asymptomatic Clostridioides difficile Colonization in Children with Cystic Fibrosis-Reference-Cited by-同舟云学术

Prevalence, Risk Factors, and Sequelae of Asymptomatic Clostridioides difficile Colonization in Children with Cystic Fibrosis

Published:2022-12 Issue: Volume: Page:
ISSN:1569-1993
Container-title:Journal of Cystic Fibrosis
language:en
Short-container-title:Journal of Cystic Fibrosis

Author:

Reasoner Seth A.^ORCID,Fazili Irtiqa F.,Bernard Rachel,Parnell Jacob M.,Sokolow Andrew G.^ORCID,Thomsen Kelly F.,Edwards Kathryn M.,Brown Rebekah F.,Nicholson Maribeth R.^ORCID

Funder

National Institutes of Health

NIAID

Thrasher Research Fund

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology and Child Health

Reference28 articles.

1. Clostridium difficile infection;Smits;Nat Rev Dis Primers,2016

2. Clostridium difficile infection in cystic fibrosis: an uncommon but life-threatening complication;Piccolo;Respirol Case Rep,2017

3. Clostridium difficile carriage in adult cystic fibrosis (CF); implications for patients with CF and the potential for transmission of nosocomial infection;Burke;Journal of Cystic Fibrosis,2017

4. Clostridium difficile infection: a review;Czepiel;European Journal of Clinical Microbiology and Infectious Diseases,2019

5. The role of Clostridium difficile in the paediatric and neonatal gut — A narrative review;Lees;European Journal of Clinical Microbiology and Infectious Diseases,2016

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gut microbiome changes in mouse, Mongolian gerbil, and hamster models following Clostridioides difficile challenge;Frontiers in Microbiology;2024-04-04

2. Longitudinal profiling of the intestinal microbiome in children with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor;mBio;2024-02-14

3. Longitudinal Profiling of the Intestinal Microbiome in Children with Cystic Fibrosis Treated with Elexacaftor-Tezacaftor-Ivacaftor;2023-08-16